4//SEC Filing
Young Jonathan 4
Accession 0001193125-25-300488
CIK 0001744659other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 4:03 PM ET
Size
17.6 KB
Accession
0001193125-25-300488
Insider Transaction Report
Form 4
Young Jonathan
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2025-11-24$21.09/sh+4,284$90,350→ 201,182 total - Exercise/Conversion
Common Stock
2025-11-24$28.35/sh+3,527$99,990→ 204,709 total - Exercise/Conversion
Common Stock
2025-11-24$21.10/sh+4,739$99,993→ 209,448 total - Gift
Common Stock
2025-11-26−9,259→ 200,189 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-24−4,284→ 0 totalExercise: $21.09Exp: 2029-12-12→ Common Stock (4,284 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-24−3,527→ 0 totalExercise: $28.35Exp: 2030-12-07→ Common Stock (3,527 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-24−4,739→ 0 totalExercise: $21.10Exp: 2031-12-07→ Common Stock (4,739 underlying)
Holdings
- 20,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]These shares are held in irrevocable trusts for the benefit of the Reporting Person's children. The Reporting Person's spouse is trustee of the trusts. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F2]Represents shares of the Issuer's Common Stock that the reporting person donated as a gift to a donor advised fund.
- [F3]The options are vested and currently exercisable.
Documents
Issuer
Akero Therapeutics, Inc.
CIK 0001744659
Entity typeother
Related Parties
1- filerCIK 0001779805
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 4:03 PM ET
- Size
- 17.6 KB